| 1 | (S)-4,5-dihydro-2-[2-hydroxy-3-(3,6,9-trioxadecyloxy)phenyl]-4-methyl-4-thiazo | - | - | - | - | 1件:  284 284 | 
| 2 | (S)-4,5-dihydro-2-[2-hydroxy-3-(3,6,9-trioxadecyloxy)phenyl]-4-methyl-4-thiazolecarboxylate magnesium hydroxide | 3件:  Hydroxide ion Hydroxide ion, Magnesium, Magnesium hydroxide | 1件:  D00731 
                
                    D00731
                
             | - | - | 1件:  284 284 | 
| 3 | (S)-4,5-dihydro-2[hydroxy-3-(3,6,9-trioxadecyloxy)phenyl]-4-m | - | - | - | - | 1件:  284 284 | 
| 4 | (S)-4,5-dihydro-2[hydroxy-3-(3,6,9-trioxadecyloxy)phenyl]-4-methyl-4-thiazolecarboxylate magnesium hydroxide | 3件:  Hydroxide ion Hydroxide ion, Magnesium, Magnesium hydroxide | 1件:  D00731 
                
                    D00731
                
             | - | - | 1件:  284 284 | 
| 5 | Abatacept | 1件:  Abatacept Abatacept | 1件:  D03203 
                
                    D03203
                
             | 2件:  CD80 CD80, CD86 💬 | 12件:  Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis 💬 | 26件:  11 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 271, 284, 285, 300 | 
| 6 | Alefacept | 1件:  Alefacept Alefacept | 1件:  D02800 
                
                    D02800
                
             | 1件:  CD58 CD58 💬 | 2件:  Cell adhesion molecules Cell adhesion molecules, Epstein-Barr virus infection 💬 | 6件:  37 37, 60, 65, 164, 284, 285 | 
| 7 | ALEMTUZUMAB | 1件:  Alemtuzumab Alemtuzumab | 1件:  D02802 
                
                    D02802
                
             | 1件:  CD52 CD52 💬 | - | 17件:  13 13, 15, 19, 20, 36, 43, 44, 46, 51, 60, 63, 65, 85, 96, 164, 283, 284 | 
| 8 | Allogeneic Bone Marrow Transplantation | - | - | - | - | 9件:  60 60, 62, 65, 96, 164, 283, 284, 285, 286 | 
| 9 | Allogeneic hematopoietic stem cell transplantation | - | - | - | - | 8件:  28 28, 51, 60, 62, 65, 164, 284, 285 | 
| 10 | Alpha beta depletion | - | - | - | - | 2件:  60 60, 284 | 
| 11 | Anti-Thymocyte Globulin | - | - | - | - | 18件:  11 11, 13, 14, 36, 40, 41, 42, 45, 46, 49, 51, 60, 62, 65, 164, 283, 284, 285 | 
| 12 | Antithymocyte Globulin | - | - | - | - | 3件:  60 60, 65, 284 | 
| 13 | Bone marrow transplantation | - | - | - | - | 4件:  51 51, 60, 284, 285 | 
| 14 | BPX-501 T cells | - | - | - | - | 4件:  65 65, 284, 285, 326 | 
| 15 | Busulfan | 1件:  Busulfan Busulfan | 1件:  D00248 
                
                    D00248
                
             | - | - | 13件:  19 19, 20, 28, 36, 49, 51, 60, 65, 164, 274, 284, 285, 326 | 
| 16 | Busulfan, Cyclophosphamide, ATG, GCSF | 2件:  Busulfan Busulfan, Cyclophosphamide | 3件:  D00248 
                
                    D00248
                
            , 
                
                    D00287
                
            , 
                
                    D07760
                
             | - | - | 2件:  65 65, 284 | 
| 17 | Busulfan, Fludarabine, ATG, TLI | 2件:  Busulfan Busulfan, Fludarabine | 3件:  D00248 
                
                    D00248
                
            , 
                
                    D01907
                
            , 
                
                    D07966
                
             | 1件:  RRM1 RRM1 💬 | 5件:  Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism 💬 | 2件:  65 65, 284 | 
| 18 | Campath, Fludarabine, Cyclophosphamide | 2件:  Cyclophosphamide Cyclophosphamide, Fludarabine | 4件:  D00287 
                
                    D00287
                
            , 
                
                    D01907
                
            , 
                
                    D07760
                
            , 
                
                    D07966
                
             | 1件:  RRM1 RRM1 💬 | 5件:  Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism 💬 | 2件:  65 65, 284 | 
| 19 | CD3/CD19 depleted leukocytes | - | - | - | - | 1件:  284 284 | 
| 20 | CD34 Stem Cell Selection Therapy | - | - | - | - | 3件:  60 60, 65, 284 | 
| 21 | CD45RA depleted leukocytes | - | - | - | - | 1件:  284 284 | 
| 22 | Cyclophosphamide | 1件:  Cyclophosphamide Cyclophosphamide | 2件:  D00287 
                
                    D00287
                
            , 
                
                    D07760
                
             | - | - | 45件:  11 11, 13, 14, 16, 19, 20, 26, 28, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 56, 60, 62, 65, 66, 84, 85, 93, 96, 162, 164, 172, 205, 222, 224, 256, 265, 274, 283, 284, 285, 288, 326, 331 | 
| 23 | Cyclophosphamide Dose Level 1 | 1件:  Cyclophosphamide Cyclophosphamide | 2件:  D00287 
                
                    D00287
                
            , 
                
                    D07760
                
             | - | - | 2件:  65 65, 284 | 
| 24 | Cyclophosphamide Dose Level 2 | 1件:  Cyclophosphamide Cyclophosphamide | 2件:  D00287 
                
                    D00287
                
            , 
                
                    D07760
                
             | - | - | 2件:  65 65, 284 | 
| 25 | Cyclophosphamide Dose Level 3 | 1件:  Cyclophosphamide Cyclophosphamide | 2件:  D00287 
                
                    D00287
                
            , 
                
                    D07760
                
             | - | - | 2件:  65 65, 284 | 
| 26 | Cyclophosphamide Dose Level 4 | 1件:  Cyclophosphamide Cyclophosphamide | 2件:  D00287 
                
                    D00287
                
            , 
                
                    D07760
                
             | - | - | 2件:  65 65, 284 | 
| 27 | Cyclosporine | 1件:  Cyclosporine Cyclosporine | 1件:  D00184 
                
                    D00184
                
             | 5件:  PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | 33件:  Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | 37件:  11 11, 19, 20, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 107, 162, 164, 222, 226, 228, 234, 283, 284, 285, 302 | 
| 28 | DACLIZUMAB | 1件:  Daclizumab Daclizumab | 1件:  D03639 
                
                    D03639
                
             | 1件:  IL2RA IL2RA 💬 | 11件:  Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 8件:  13 13, 56, 60, 65, 97, 107, 283, 284 | 
| 29 | Deferasirox | 1件:  Deferasirox Deferasirox | 1件:  D03669 
                
                    D03669
                
             | - | - | 3件:  254 254, 284, 286 | 
| 30 | Deferitazole | 1件:  Deferitazole Deferitazole | 1件:  D10388 
                
                    D10388
                
             | - | - | 1件:  284 284 | 
| 31 | Deferoxamine | 1件:  Deferoxamine Deferoxamine | 2件:  D01186 
                
                    D01186
                
            , 
                
                    D03670
                
             | - | - | 2件:  284 284, 286 | 
| 32 | Desferal | 1件:  Deferoxamine Deferoxamine | 2件:  D01186 
                
                    D01186
                
            , 
                
                    D03670
                
             | - | - | 2件:  284 284, 286 | 
| 33 | DFO | - | - | - | - | 3件:  46 46, 284, 286 | 
| 34 | ELTROMBOPAG | 1件:  Eltrombopag Eltrombopag | - | - | - | 5件:  60 60, 63, 65, 284, 285 | 
| 35 | Enriched Hematopoetic Stem Cell Infusion | - | - | - | - | 3件:  13 13, 19, 284 | 
| 36 | Exjade | 1件:  Deferasirox Deferasirox | 1件:  D03669 
                
                    D03669
                
             | - | - | 3件:  254 254, 284, 286 | 
| 37 | FBS0701 | - | - | - | - | 1件:  284 284 | 
| 38 | FBS0701 CAPSULE | - | - | - | - | 1件:  284 284 | 
| 39 | FBS0701/SSP004184 | - | - | - | - | 1件:  284 284 | 
| 40 | Filgrastim | 1件:  Filgrastim Filgrastim | 1件:  D03235 
                
                    D03235
                
             | 1件:  CSF3R CSF3R 💬 | 5件:  Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | 28件:  2 2, 6, 13, 25, 26, 28, 34, 35, 38, 40, 41, 42, 45, 46, 49, 51, 60, 62, 65, 96, 113, 164, 256, 283, 284, 285, 296, 331 | 
| 41 | Fludarabine | 1件:  Fludarabine Fludarabine | 2件:  D01907 
                
                    D01907
                
            , 
                
                    D07966
                
             | 1件:  RRM1 RRM1 💬 | 5件:  Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism 💬 | 18件:  13 13, 28, 36, 46, 49, 51, 60, 61, 62, 65, 85, 96, 164, 283, 284, 285, 286, 326 | 
| 42 | Fludarabine monophosphate | 1件:  Fludarabine Fludarabine | 2件:  D01907 
                
                    D01907
                
            , 
                
                    D07966
                
             | 1件:  RRM1 RRM1 💬 | 5件:  Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism 💬 | 3件:  65 65, 284, 326 | 
| 43 | Fludarabine phosphate | 2件:  Fludarabine Fludarabine, Phosphate ion | 2件:  D01907 
                
                    D01907
                
            , 
                
                    D07966
                
             | 1件:  RRM1 RRM1 💬 | 5件:  Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism 💬 | 12件:  28 28, 36, 49, 51, 60, 62, 65, 96, 283, 284, 285, 286 | 
| 44 | G-CSF | 1件:  Filgrastim Filgrastim | 1件:  D03235 
                
                    D03235
                
             | 1件:  CSF3R CSF3R 💬 | 5件:  Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | 16件:  2 2, 6, 11, 13, 16, 47, 49, 51, 60, 62, 65, 85, 96, 284, 285, 331 | 
| 45 | Human Placental Derived Stem Cell | - | - | - | - | 4件:  19 19, 20, 60, 284 | 
| 46 | Hydroxide | 1件:  Hydroxide ion Hydroxide ion | - | - | - | 5件:  11 11, 46, 96, 97, 284 | 
| 47 | Hydroxyurea | 1件:  Hydroxyurea Hydroxyurea | 1件:  D00341 
                
                    D00341
                
             | 1件:  RRM2 RRM2 💬 | 6件:  Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism, p53 signaling pathway 💬 | 8件:  3 3, 13, 19, 20, 65, 85, 86, 284 | 
| 48 | ICL670 | - | - | - | - | 3件:  60 60, 284, 286 | 
| 49 | Iron | 1件:  Iron Iron | - | - | - | 6件:  18 18, 96, 97, 238, 254, 284 | 
| 50 | IRON CHELATING AGENTS | - | - | - | - | 1件:  284 284 | 
| 51 | L-leucine | 1件:  Leucine Leucine | 1件:  D00030 
                
                    D00030
                
             | - | - | 1件:  284 284 | 
| 52 | Lenalidomide | 1件:  Lenalidomide Lenalidomide | 1件:  D04687 
                
                    D04687
                
             | 1件:  TNF TNF 💬 | 67件:  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 8件:  16 16, 26, 28, 34, 49, 284, 300, 331 | 
| 53 | Leucine | 1件:  Leucine Leucine | 1件:  D00030 
                
                    D00030
                
             | - | - | 11件:  5 5, 6, 7, 19, 65, 96, 97, 127, 283, 284, 299 | 
| 54 | Leukapheresis | - | - | - | - | 5件:  49 49, 51, 96, 284, 285 | 
| 55 | Magnesium | 1件:  Magnesium Magnesium | - | - | - | 19件:  3 3, 6, 11, 13, 15, 46, 64, 70, 93, 97, 166, 225, 235, 256, 284, 291, 296, 297, 298 | 
| 56 | Magnesium hydroxide | 3件:  Hydroxide ion Hydroxide ion, Magnesium, Magnesium hydroxide | 1件:  D00731 
                
                    D00731
                
             | - | - | 1件:  284 284 | 
| 57 | Melphalan | 1件:  Melphalan Melphalan | 1件:  D00369 
                
                    D00369
                
             | - | - | 15件:  11 11, 13, 14, 19, 20, 28, 60, 62, 65, 96, 164, 234, 284, 285, 299 | 
| 58 | Mesenchymal Stromal Cells | 1件:  Human Umbilical Cord Mesenchymal Stem Cells Human Umbilical Cord Mesenchymal Stem Cells | - | - | - | 10件:  2 2, 36, 49, 51, 60, 96, 97, 107, 274, 284 | 
| 59 | Methotrexate | 1件:  Methotrexate Methotrexate | 2件:  D00142 
                
                    D00142
                
            , 
                
                    D02115
                
             | 2件:  DHFR DHFR, DHFR2 💬 | 5件:  Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 38件:  11 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 270, 271, 283, 284, 285, 286, 326, 331 | 
| 60 | Methylprednisolone | 1件:  Methylprednisolone Methylprednisolone | 6件:  D00407 
                
                    D00407
                
            , 
                
                    D00751
                
            , 
                
                    D00979
                
            , 
                
                    D05000
                
            , 
                
                    D05001
                
            , 
                
                    D05002
                
             | 1件:  NR3C1 NR3C1 💬 | 1件:  Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 48件:  2 2, 6, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 86, 93, 95, 96, 97, 127, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296, 300 | 
| 61 | Mycophenolate | 1件:  Mycophenolic acid Mycophenolic acid | 1件:  D05096 
                
                    D05096
                
             | 2件:  IMPDH1 IMPDH1, IMPDH2 💬 | 3件:  Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism 💬 | 36件:  2 2, 11, 13, 19, 20, 28, 35, 36, 42, 43, 44, 45, 49, 51, 53, 60, 61, 62, 65, 66, 84, 85, 93, 95, 96, 162, 164, 222, 224, 226, 228, 234, 283, 284, 285, 300 | 
| 62 | Mycophenolate mofetil | 2件:  Mycophenolate mofetil Mycophenolate mofetil, Mycophenolic acid | 4件:  D00752 
                
                    D00752
                
            , 
                
                    D05094
                
            , 
                
                    D05095
                
            , 
                
                    D05096
                
             | 2件:  IMPDH1 IMPDH1, IMPDH2 💬 | 3件:  Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism 💬 | 34件:  2 2, 11, 13, 19, 20, 28, 35, 36, 42, 43, 44, 45, 49, 51, 53, 60, 61, 62, 65, 66, 85, 93, 95, 96, 162, 164, 222, 224, 226, 234, 283, 284, 285, 300 | 
| 63 | Myeloablative Preparative Regimen | - | - | - | - | 3件:  62 62, 65, 284 | 
| 64 | Other: Laboratory Biomarker Analysis | - | - | - | - | 21件:  11 11, 13, 14, 26, 28, 34, 49, 51, 60, 62, 65, 89, 96, 97, 205, 232, 283, 284, 285, 298, 331 | 
| 65 | Peripheral Blood Stem Cell Transplantation | - | - | - | - | 12件:  11 11, 13, 14, 28, 51, 60, 62, 65, 283, 284, 285, 286 | 
| 66 | Phosphate | 1件:  Phosphate ion Phosphate ion | - | - | - | 33件:  2 2, 3, 6, 11, 12, 13, 15, 28, 36, 46, 49, 51, 53, 60, 62, 65, 70, 78, 81, 83, 90, 96, 97, 164, 235, 238, 256, 276, 283, 284, 285, 286, 299 | 
| 67 | Prednisone | 1件:  Prednisone Prednisone | 1件:  D00473 
                
                    D00473
                
             | 1件:  NR3C1 NR3C1 💬 | 1件:  Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 48件:  2 2, 6, 11, 13, 14, 19, 26, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 61, 63, 64, 65, 66, 79, 81, 84, 85, 86, 95, 96, 97, 113, 127, 162, 164, 205, 222, 224, 228, 251, 283, 284, 285, 288, 299, 300, 331 | 
| 68 | Radiation therapy | - | - | - | - | 3件:  13 13, 284, 285 | 
| 69 | Radiation: radiation therapy | - | - | - | - | 5件:  34 34, 60, 65, 284, 285 | 
| 70 | Radiation: Total Body Irradiation | - | - | - | - | 7件:  36 36, 49, 51, 60, 65, 283, 284 | 
| 71 | Radiation: total-body irradiation | - | - | - | - | 9件:  28 28, 51, 60, 62, 65, 96, 283, 284, 285 | 
| 72 | Reduced Intensity Preparative Regimen | - | - | - | - | 3件:  62 62, 65, 284 | 
| 73 | Reduced Toxicity Ablative Regimen | - | - | - | - | 3件:  62 62, 65, 284 | 
| 74 | Rimiducid | 1件:  Rimiducid Rimiducid | 1件:  D11195 
                
                    D11195
                
             | 1件:  CASP9 CASP9 💬 | 35件:  Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Apoptosis, Apoptosis - multiple species, Colorectal cancer, Endometrial cancer, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Huntington disease, Influenza A, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Lipid and atherosclerosis, Measles, Non-small cell lung cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parkinson disease, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platinum drug resistance, Prion disease, Prostate cancer, Small cell lung cancer, Thyroid hormone signaling pathway, Toxoplasmosis, Tuberculosis, VEGF signaling pathway, Viral myocarditis, p53 signaling pathway 💬 | 6件:  19 19, 60, 65, 284, 285, 326 | 
| 75 | Rituximab | 1件:  Rituximab Rituximab | 1件:  D02994 
                
                    D02994
                
             | 1件:  MS4A1 MS4A1 💬 | 1件:  Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 49件:  6 6, 11, 13, 14, 17, 19, 35, 36, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 127, 162, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 | 
| 76 | Rivogenlecleucel | - | - | - | - | 6件:  19 19, 60, 65, 284, 285, 326 | 
| 77 | SOTATERCEPT | 1件:  Sotatercept Sotatercept | 1件:  D09670 
                
                    D09670
                
             | 1件:  ACVR2A ACVR2A 💬 | 4件:  Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Signaling pathways regulating pluripotency of stem cells, TGF-beta signaling pathway 💬 | 2件:  86 86, 284 | 
| 78 | Sotatercept with prednisone boost | 2件:  Prednisone Prednisone, Sotatercept | 2件:  D00473 
                
                    D00473
                
            , 
                
                    D09670
                
             | 2件:  ACVR2A ACVR2A, NR3C1 💬 | 5件:  Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Neuroactive ligand-receptor interaction, Signaling pathways regulating pluripotency of stem cells, TGF-beta signaling pathway 💬 | 1件:  284 284 | 
| 79 | SSP-004184 100 mg | - | - | - | - | 1件:  284 284 | 
| 80 | SSP-004184 100 mg Capsule | - | - | - | - | 1件:  284 284 | 
| 81 | SSP-004184 250 mg | - | - | - | - | 1件:  284 284 | 
| 82 | SSP-004184 250 mg Capsule | - | - | - | - | 1件:  284 284 | 
| 83 | SSP-004184 375 mg | - | - | - | - | 1件:  284 284 | 
| 84 | SSP-004184 375 mg Capsule | - | - | - | - | 1件:  284 284 | 
| 85 | SSP-004184 50 mg | - | - | - | - | 1件:  284 284 | 
| 86 | SSP-004184 50 mg Capsule | - | - | - | - | 1件:  284 284 | 
| 87 | SSP-004184 500 mg | - | - | - | - | 1件:  284 284 | 
| 88 | SSP-004184 500 mg Capsule | - | - | - | - | 1件:  284 284 | 
| 89 | SSP-004184AQ 100 mg | - | - | - | - | 1件:  284 284 | 
| 90 | SSP-004184AQ 100 mg Capsule | - | - | - | - | 1件:  284 284 | 
| 91 | SSP-004184AQ 200 mg | - | - | - | - | 1件:  284 284 | 
| 92 | SSP-004184AQ 200 mg Capsule | - | - | - | - | 1件:  284 284 | 
| 93 | SSP-004184AQ 250 mg | - | - | - | - | 1件:  284 284 | 
| 94 | SSP-004184AQ 250 mg Capsule | - | - | - | - | 1件:  284 284 | 
| 95 | SSP-004184AQ 375 mg | - | - | - | - | 1件:  284 284 | 
| 96 | SSP-004184AQ 375 mg Capsule | - | - | - | - | 1件:  284 284 | 
| 97 | SSP-004184AQ 50 mg | - | - | - | - | 1件:  284 284 | 
| 98 | SSP-004184AQ 50 mg Capsule | - | - | - | - | 1件:  284 284 | 
| 99 | Stem Cell Infusion | - | - | - | - | 5件:  28 28, 60, 65, 284, 285 | 
| 100 | Stem Cell Transplant | - | - | - | - | 6件:  19 19, 20, 60, 65, 164, 284 | 
| 101 | Tacrolimus | 1件:  Tacrolimus Tacrolimus | 2件:  D00107 
                
                    D00107
                
            , 
                
                    D08556
                
             | 5件:  PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | 33件:  Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | 34件:  2 2, 6, 11, 13, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 286, 299 | 
| 102 | Thiotepa | 1件:  Thiotepa Thiotepa | 1件:  D00583 
                
                    D00583
                
             | - | - | 12件:  13 13, 19, 20, 28, 51, 60, 65, 85, 96, 164, 284, 285 | 
| 103 | Thiotepa--escalated dose | 1件:  Thiotepa Thiotepa | 1件:  D00583 
                
                    D00583
                
             | - | - | 4件:  19 19, 20, 65, 284 | 
| 104 | Thiotepa--single daily dose | 1件:  Thiotepa Thiotepa | 1件:  D00583 
                
                    D00583
                
             | - | - | 4件:  19 19, 20, 65, 284 | 
| 105 | Total lymphoid irradiation | - | - | - | - | 3件:  65 65, 284, 326 | 
| 106 | Trifluoperazine | 1件:  Trifluoperazine Trifluoperazine | 3件:  D00799 
                
                    D00799
                
            , 
                
                    D01448
                
            , 
                
                    D08636
                
             | 1件:  DRD2 DRD2 💬 | 8件:  Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 2件:  283 283, 284 | 
| 107 | Umbilical Cord Blood Transplantation | - | - | - | - | 5件:  60 60, 65, 284, 285, 326 |